Ostrum Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.84M Buy
61,875
+3,381
+6% +$273K 0.23% 59
2026
Q1
$5.07M Buy
58,494
+24,290
+71% +$2.33M 0.28% 49
2025
Q4
$3.29M Sell
34,204
-6,115
-15% -$594K 0.16% 98
2025
Q3
$3.84M Sell
40,319
-9,077
-18% -$834K 0.17% 101
2025
Q2
$4.31M Buy
49,396
+13,629
+38% +$1.16M 0.2% 89
2025
Q1
$3.21M Sell
35,767
-9,332
-21% -$835K 0.17% 114
2024
Q4
$3.6M Buy
45,099
+11,015
+32% +$954K 0.31% 81
2024
Q3
$3.07M Sell
34,084
-887
-3% -$74.6K 0.25% 123
2024
Q2
$2.75M Sell
34,971
-642
-2% -$52.6K 0.24% 138
2024
Q1
$3.1M Buy
35,613
+6,138
+21% +$524K 0.25% 120
2023
Q4
$2.43M Buy
29,475
+16,394
+125% +$1.25M 0.21% 155
2023
Q3
$1.03M Sell
13,081
-14,774
-53% -$1.24M 0.09% 303
2023
Q2
$2.45M Sell
27,855
-487
-2% -$41.9K 0.21% 165
2023
Q1
$2.28M Buy
+28,342
New +$2.31M 0.2% 178

Other funds holding MDT

Ostrum Asset Management's MDT Position: Q2 2026 in Review

Ostrum Asset Management increased its Medtronic (MDT) stake by 5.8% in Q2 2026, buying an estimated $273K and bringing the position to 61,875 shares worth $4.84M. The position accounts for 0.23% of the portfolio, ranked #59.

Ostrum Asset Management first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.07M in Q1 2026. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ostrum Asset Management held 61,875 shares of Medtronic worth $4.84M as of Q2 2026.
  • Ostrum Asset Management bought 3,381 Medtronic shares in Q2 2026, an estimated $273K.
  • Medtronic made up 0.23% of Ostrum Asset Management's portfolio in Q2 2026, its #59 holding.
  • Ostrum Asset Management first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • Ostrum Asset Management's Medtronic position peaked at $5.07M in Q1 2026.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.